Indefinite Delivery Contract SPE2D222D0150

Award Date 9/29/22
Last Date to Order 9/28/27
Federal Agency
Medical Supply Chain
Awardee
Specgx LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The $29.25 million single-award IDC, which does not have a set-aside, will provide a national supply source for a variety of hydrocodone-acetaminophen tablet products in 100 and 500 count bottles to support Department of Defense, Department of Veterans Affairs, Indian...
The Indefinite Delivery Contract (IDC) SPE2D224D0008 was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The $5.89 million single-award IDC, with a period of performance through September 2029, is an unrestricted contract vehicle that enables the DLA, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs to efficiently procure a variety of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC enables the DLA to issue firm fixed-price delivery orders for...
The Indefinite Delivery Contract (IDC) SPE2DX15D9507 was awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The IDC has a ceiling value of $4,999,999.00 and is valid through December 31, 2025. Under this single-award IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $4,999,999 single-award contract, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $4,999,999 single-award contract, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a ceiling value of $6,939,222.50, awarded on July 15, 2019 to the prime contractor Specgx LLC, doing business as Mallinckrodt Pharmaceuticals. The contract was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, to establish a national supply source for pharmaceutical products used by the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a comprehensive portfolio of...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned pharmaceutical manufacturer. The $7,299,519.55 single-award contract has a period of performance through September 28, 2027.

The contract aims to establish a national supply source for the DLA, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons to procure various dosages and quantities of Oxycodone HCL-Acetaminophen tablets. These controlled substance pharmaceuticals are primarily used for pain management, substance abuse treatment, and medical research across federal healthcare systems. The IDC will allow these agencies to efficiently order these critical pharmaceutical products through established prime vendor programs to support their medical treatment, research, and operational needs.

Generated 7/27/25, 12:46 AM